Cite
HARVARD Citation
Maxwell, S. et al. (n.d.). DEVELOPMENT OF NOVEL, NON‐TOXIC RIFAMYCINS THAT REVERSE DRUG RESISTANCE IN DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL). Hematological oncology. pp. 253-254. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Maxwell, S. et al. (n.d.). DEVELOPMENT OF NOVEL, NON‐TOXIC RIFAMYCINS THAT REVERSE DRUG RESISTANCE IN DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL). Hematological oncology. pp. 253-254. [Online].